Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.89% Nasdaq Up1.26%

Teva Pharmaceutical Industries Limited (TEVA)

-NYQ

37.80 Down 0.30(0.79%) 4:04PM EDT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Net Income 1,963,000   2,759,000   3,331,000  
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,708,000  1,069,000  977,000  
Adjustments To Net Income540,000  (297,000)25,000  
Changes In Accounts Receivables -   -   -  
Changes In Liabilities -   -   -  
Changes In Inventories -   -   -  
Changes In Other Operating Activities414,000  594,000  (205,000)
Total Cash Flow From Operating Activities 4,572,000   4,134,000   4,136,000  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(1,104,000)(1,053,000)(710,000)
Investments(201,000)(217,000)(436,000)
Other Cash flows from Investing Activities171,000  (6,331,000)(4,309,000)
Total Cash Flows From Investing Activities (1,134,000) (7,601,000) (5,455,000)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid(855,000)(800,000)(668,000)
Sale Purchase of Stock(1,147,000)(903,000)81,000  
Net Borrowings319,000  5,034,000  1,146,000  
Other Cash Flows from Financing Activities5,000  5,000  14,000  
Total Cash Flows From Financing Activities (1,678,000) 3,336,000   573,000  
Effect Of Exchange Rate Changes23,000  (21,000)(1,000)
Change In Cash and Cash Equivalents 1,783,000   (152,000) (747,000)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.